SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001070081-19-000046
Filing Date
2019-08-05
Accepted
2019-08-05 08:09:46
Documents
3
Period of Report
2019-08-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8-k080519.htm 8-K 30607
2 EXHIBIT 99.1 ex991hopewellpressrelease.htm EX-99.1 11978
3 ex991hopewellpressrel_image1.gif GRAPHIC 4220
  Complete submission text file 0001070081-19-000046.txt   49933
Mailing Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449
Business Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449 9082227000
PTC THERAPEUTICS, INC. (Filer) CIK: 0001070081 (see all company filings)

IRS No.: 043416587 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35969 | Film No.: 19997608
SIC: 2834 Pharmaceutical Preparations